The effect of propolis produced by Apis mellifera as a nutritional supplement on the expression level of NF-κB and LC3 anti-inflammatory immune genes in Iraqi Hamdani sheep
DOI:
https://doi.org/10.59658/jkas.v12i2.3792Keywords:
LC3, NF-ĸB, propolis, cDNA and Real-Time PCRAbstract
This research aimed to measure the expression levels of the genes LC3 and NF-ĸB in Hamdani sheep blood that were fed with Apis mellifera propolis. Propolis, a bee product, has been utilized for centuries due to its numerous biological advantages. It was incorporated into their daily diet for six weeks. Propolis is well-known for its antimicrobial, anti-inflammatory, and immune-modulating effects in both animals and humans. The propolis was introduced to the diet every two weeks in quantities of 2, 3, and 4 grams. Following this, blood samples were collected from these 10 sheep biweeklies, and on the same day, RNA was extracted in the lab and converted into cDNA. The expression levels of the genes LC3 and NF-ĸB were assessed using a Real-Time PCR machine, and the ΔΔCt values were calculated based on reference gene expression. The gathered data were analyzed using the GraphPad software, revealing that the expression of the target genes increased when compared to the control data, with the optimal amount of bee propolis additive being 4 grams per day.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Copyright (c) 2024 is the Author's article. Published by the Journal of Kerbala for Agricultural Sciences under a CC BY 4.0 license
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing Terms
All articles are published under a Creative Commons License and will be directed to the Creative Commons Attribution 4.0 International License (CC BY 4.0) That permits use, distribution, and reproduction in any medium, provided the original work is properly cited. This license also allows the work to be used for commercial purposes.
Use by both non-commercial and commercial users
This content is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, permitting use by both non-commercial and commercial users. Individual users may access, download, copy, display, and redistribute the articles to colleagues, as well as adapt, translate, and text- and data-mine the content, subject to the following conditions:
- The author's moral rights, including the right of attribution and the right to protect their work from derogatory treatment, are respected.
- Where content in the article is identified as belonging to a third party, users must ensure that any reuse complies with the copyright policies of the owner of that content.
- If the article content is reused for research or educational purposes, users should maintain a link to the appropriate bibliographic citation, including the DOI and a link to the published version on the journal's website.
